Vivos Therapeutics (VVOS) Interest Coverage Ratio Growth (1y) (2021 - 2026)
Vivos Therapeutics (VVOS) Interest Coverage Ratio Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.80 Bn | 176.50 Bn | 6.27 Bn | -45.18% |
| 2 | Stryker | 128.84 Bn | 125.96 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn | 59.82% |
| 4 | Boston Scientific | 68.51 Bn | 67.06 Bn | 3.61 Bn | -80.85% |
| 5 | Edwards Lifesciences | 48.18 Bn | 44.51 Bn | 1.29 Bn | 11.06% |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn | 189.50% |
| 7 | GE HealthCare Technologies | 28.16 Bn | 25.88 Bn | 1.98 Bn | -6.18% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn | -54.61% |
| 10 | Vivos Therapeutics | 5.79 Mn | 3.68 Mn | 3.06 Mn | 103.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 103.56% |
| Dec 31, 2025 | 99.43% |
| Sep 30, 2025 | 115.36% |
| Jun 30, 2025 | 270.88% |
| Mar 31, 2025 | -7,759.92% |
| Dec 31, 2024 | -21,931.14% |
| Sep 30, 2024 | -6,181.75% |
| Jun 30, 2024 | -131.17% |
| Mar 31, 2024 | 83.03% |
| Dec 31, 2023 | 54.20% |
| Sep 30, 2023 | 82.44% |
| Jun 30, 2023 | 83.14% |
| Mar 31, 2023 | 84.74% |
| Dec 31, 2022 | 99.25% |
| Sep 30, 2022 | -193.48% |
| Jun 30, 2022 | -183.78% |
| Mar 31, 2022 | -94.92% |
| Dec 31, 2021 | -2,108.39% |
| Sep 30, 2021 | -720.84% |
| Jun 30, 2021 | -1,226.76% |